Subdivision
• | 204. Medicine, Surgery, Pathology and Immunology | [X] |
| 21 | Name: | Dr. David G. Nathan | | Institution: | Dana-Farber Cancer Institute & Harvard Medical School | | Year Elected: | 1999 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1929 | | | | | David Nathan is one of the most distinguished pediatric hematologists in the country. He has spent his career at Harvard University, where he has been a professor of medicine and professor of pediatrics, and in 1985 he was appointed Pediatrician-in-Chief at Childrens Hospital in Boston. In 1995 he became President of the Dana-Farber Cancer Institute. Dr. Nathan has brought to his position scientific excellence, great integrity and a warm humanity. Among other awards he has received the National Medal of Science (1990) and the Henry Stratton Medal of the American Society of Hematology (1995). He earned his M.D. from Harvard Medical School in 1955. | |
22 | Name: | Dr. Peter Carey Nowell | | Institution: | University of Pennsylvania | | Year Elected: | 1993 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1928 | | Death Date: | December 26, 2016 | | | | | A professor of pathology at the University of Pennsylvania from 1964 to his retirement in 2008, Peter Carey Nowell was a creative and distinguished scholar who was internationally recognized for discovery of the Philadelphia chromosome in granulocytic leukemia - the first constant chromosomal abnormality specifically associated with any form of cancer. This discovery led to the founding of an entirely new field of research: cancer cytogenetics. Some of Dr. Nowell's other important medical discoveries are less well known. He was the first to demonstrate that bone marrow transplantation could save lethally irradiated animals, and he was also the first to show that certain sugar-containing plant products (lectins) caused white blood cells to divide, a property that has been widely used in medical research. He also proposed a widely-accepted theory to explain the evolution of malignancy among the cells of tumors. With hundreds of publications to his credit, including more than a few "citation classics," Dr. Nowell was an academic leader who has served as both director of the cancer center and chairman of pathology at the University of Pennsylvania. In 1952 he received his M.D. from the University of Pennsylvania School of Medicine, and he has worked there throughout his career. A past president of the American Society for Experimental Pathology, Dr. Nowell was also a member of the National Academy of Sciences and the recipient of awards such as the Leukemia Society of America's Robert de Villiers Award (1987), the Memorial Sloan Kettering Cancer Center's Fred W. Stewart Award (1989), and the Franklin Institute's Benjamin Franklin Medal in Life Science (2009). Peter Nowell died December 26, 2016, at age 88. | |
23 | Name: | Dr. Paul A. Offit | | Institution: | Childrens Hospital of Philadelphia; University of Pennsylvania | | Year Elected: | 2023 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1951 | | | | | Paul A. Offit, MD is the Director of the Vaccine Education Center at the Children’s Hospital of Philadelphia as well as the Maurice R. Hilleman Professor of Vaccinology and a Professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. He is a recipient of many awards including the J. Edmund Bradley Prize for Excellence in Pediatrics from the University of Maryland Medical School, the Young Investigator Award in Vaccine Development from the Infectious Disease Society of America, and a Research Career Development Award from the National Institutes of Health. Dr. Offit has published more than 160 papers in medical and scientific journals in the areas of rotavirus-specific immune responses and vaccine safety. He is also the co-inventor of the rotavirus vaccine, RotaTeq, recommended for universal use in infants by the CDC in 2006 and by the WHO in 2013; for this achievement Dr. Offit received the Luigi Mastroianni and William Osler Awards from the University of Pennsylvania School of Medicine, the Charles Mérieux Award from the National Foundation for Infectious Diseases; and was honored by Bill and Melinda Gates during the launch of their Foundation’s Living Proof Project for global health. In 2009, Dr. Offit received the President’s Certificate for Outstanding Service from the American Academy of Pediatrics. In 2011, Dr. Offit received the David E. Rogers Award from the American Association of Medical Colleges, the Odyssey Award from the Center for Medicine in the Public Interest and was elected to the Institute of Medicine of the National Academy of Sciences. In 2012, Dr. Offit received the Distinguished Medical Achievement Award from the College of Physicians of Philadelphia. In 2013, Dr. Offit received the Maxwell Finland award for Outstanding Scientific Achievement from the National Foundation for Infectious Diseases and the Distinguished Alumnus award from the University of Maryland School of Medicine. In 2015, Dr. Offit won the Lindback Award for Distinguished Teaching from the University of Pennsylvania and was elected to the American Academy of Arts and Sciences. In 2016, Dr. Offit won the Franklin Founder Award from the city of Philadelphia, The Porter Prize from the University of Pittsburgh School of Public Health, the Lifetime Achievement Award from the Philadelphia Business Journal, and the Jonathan E. Rhoads Medal for Distinguished Service to Medicine from the American Philosophical Society. In 2018, Dr. Offit received the Gold Medal from the Sabin Vaccine Institute and in 2019 the John P. McGovern Award from the American Medical Writers Association and in 2020 the Public Educator Award from CHILD USA. In 2021, Dr. Offit was awarded the Edward Jenner Lifetime Achievement Award in Vaccinology from the 15th Vaccine Congress and was elected to the Baltimore Jewish Hall of Fame. In 2022, Dr. Offit received the Mentor of the Year Award from the Eastern Society for Pediatric Research and the Dean’s Alumni Leadership Award from the University of Maryland School of Medicine. Dr. Offit was a member of the Advisory Committee on Immunization Practices to the Centers for Disease Control and Prevention, is currently a member of the FDA’s Vaccine Advisory Committee and is a founding advisory board member of the Autism Science Foundation and the Foundation for Vaccine Research. He is also the author of ten medical narratives: The Cutter Incident: How America’s First Polio Vaccine Led to Today’s Growing Vaccine Crisis (Yale University Press, 2005), Vaccinated: One Man’s Quest to Defeat the World’s Deadliest Diseases (HarperCollins, 2007), for which he won an award from the American Medical Writers Association, Autism’s False Prophets: Bad Science, Risky Medicine, and the Search for a Cure (Columbia University Press, 2008), Deadly Choices: How the Anti-Vaccine Movement Threatens Us All (Basic Books, 2011), which was selected by Kirkus Reviews and Booklist as one of the best non-fiction books of the year, Do You Believe in Magic?: The Sense and Nonsense of Alternative Medicine (HarperCollins, 2013), which won the Robert P. Balles Prize in Critical Thinking from the Center for Skeptical Inquiry and was selected by National Public Radio as one of the best books of 2013, Bad Faith: When Religious Belief Undermines Modern Medicine (Basic Books, 2015), which was selected by the New York Times Book Review as an "Editor’s Choice" book in April 2015, Pandora’s Lab: Seven Stories of Science Gone Wrong (National Geographic Press/Random House, April 2017), which was nominated for Best Science and Technology book of 2017 by Goodreads, Bad Advice: Or Why Celebrities, Politicians, and Activists Aren’t Your Best Source of Health Information (Columbia University Press, June 2018), Overkill: When Modern Medicine Goes Too Far (HarperCollins, April, 2020), You Bet Your Life: From Blood Transfusions to Mass Vaccinations: The Long and Risky History of Medical Innovations (Basic Books, 2021), which was nominated for the Phi Beta Kappa Award in Science, and Tell Me When It’s Over: Living with COVID in a Post-Pandemic World (National Geographic Press, in press, 2024). | |
24 | Name: | Dr. Olufunmilayo Olopade | | Institution: | University of Chicago | | Year Elected: | 2011 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1957 | | | | | Olufunmilayo Olopade occupies a unique place in medicine. Born and educated in Nigeria, where she earned her M.D. from the University of Ibadan in 1980, she has been on the faculty of University of Chicago since 1986. She specializes in cancer risk assessment prevention, early detection and treatment of aggressive breast cancer that disproportionately affects young women. Olopade has done pioneering work in genomic analysis of breast cancer, including seminal work in young Nigerian breast cancer patients harboring BRCA1 and BRCA2 variants. This work in comparative genomics has the potential to reduce the burden of cancer and improve health in developing nations. She has been recognized with many honors, including the Distinguished Clinical Scientist Award of the Doris Duke Charitable Foundation in 2000, a MacArthur Fellowship in 2005, and the 2017 Mendel Medal Lecture at Villanova University. She is a member of a number of scholarly communities, including the American Association for Cancer Research, the Association of American Physicians (2005), the National Academy of Sciences (2008), the Institute of Medicine (2008), and the American Academy of Arts & Sciences (2010). She was elected a member of the American Philosophical Society in 2011. | |
25 | Name: | Dr. Stuart H. Orkin | | Institution: | Harvard University; Howard Hughes Medical Institute | | Year Elected: | 2017 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1946 | | | | | Stuart Orkin has made pioneering achievements in defining the molecular basis of blood disorders and fundamental regulatory mechanisms governing the development of blood stem cells and blood lineages. His research is unmatched for its combined impact on our understanding of the genetic basis of blood diseases, the control of hematopoiesis, and the basis of the human fetal (HbF) to adult hemoglobin switch. He provided the first comprehensive molecular dissection of an inherited disorder, the thalassemia syndromes, and isolated the first regulator of blood cell development (GATA1). He identified the first disease gene (X-linked chronic granulomatous disease) through positional cloning. In the past decade, he defined how HbF is silenced in adult red cells starting with genome-wide association studies (GWAS) through to gene editing, work that forms the basis for therapeutic trials to reactivate HbF in thalassemia and sickle cell disease patients. His research is a paradigm for the application of molecular genetics to medicine. In 2018 he was the recipient of the Mecthild Esser Nemmers Prize in Medical Science, in 2020 he was awarded the King Faisal Prize in Medicine, and in 2021 he was awarded the 2021 Gruber Genetics Prize. | |
26 | Name: | Dr. Jonathan E. Rhoads | | Institution: | University of Pennsylvania | | Year Elected: | 1958 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1907 | | Death Date: | January 3, 2002 | | | |
27 | Name: | Dr. Frederick C. Robbins | | Institution: | Case Western Reserve University | | Year Elected: | 1972 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1916 | | Death Date: | August 4, 2003 | | | |
28 | Name: | Dr. Seymour I. Schwartz | | Institution: | University of Rochester | | Year Elected: | 2001 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1928 | | Death Date: | August 28, 2020 | | | | | Seymour I. Schwartz was the Distinguished Alumni Professor of Surgery at the University of Rochester School of Medicine and Dentistry and was Chair of the Department of Surgery from 1987-1998. He received his medical training from New York University. Dr. Schwartz has authored or edited several surgical textbooks, including seven editions of the most widely read Principles of Surgery, and is Editor Emeritus of the Journal of the American College of Surgeons. His many contributions were recognized in 1992 when he was awarded the Albert Kaiser Medal. Dr. Schwartz is also a cartographic historian and has authored Mapping of America 1980), The French and Indian War (1995), An Englishman\'s Journey Along American\'s Eastern Waterway\'s (2000), This Land is Your Land: The Geographic Evolution of the United States (2000), Putting \"America\" on the Map (2007) and Gifted Hands (2009). He was on the Board of the National Museum of American History of the Smithsonian Institution and the Phillips Society of the Library of Congress. He was elected a member of the American Philosophical Society in 2001. Seymour Schwartz died on August 28, 2020 at his son's home in St. Louis, Missouri. | |
29 | Name: | Dr. Christine Edry Seidman | | Institution: | Harvard University | | Year Elected: | 2024 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1952 | | | |
30 | Name: | Dr. Thomas E. Starzl | | Institution: | University of Pittsburgh School of Medicine | | Year Elected: | 1999 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1926 | | Death Date: | March 4, 2017 | | | | | Thomas E. Starzl was director emeritus of the Thomas E. Starzl Transplantation Institute of the University of Pittsburgh and the University of Pittsburgh Medical Center at the time of his death March 4, 2017, at age 90. He received his Ph.D. in neurophysiology and his M.D. degrees at Northwestern University. Completing surgical training at The Johns Hopkins University and the University of Miami, he became a Markle Scholar and faculty member at Northwestern University. In 1962, shortly after joining the faculty at the University of Colorado, Dr. Starzl performed his first kidney transplant and subsequently the world's first human liver transplant. Within a year, he had more kidney transplant recipients surviving than all other surgeons combined. He improved immunosuppression with anti-lymphocyte globulin (ALG), cyclosporine-based treatment and tacrolimus. Largely through Dr. Starzl's efforts, transplantation of all organs came of age. Dr. Starzl joined the University of Pittsburgh faculty in 1981and performed the first of 30 liver transplants at the university that year, helping make the city the "transplant capital of the world." Retiring from clinical practice in 1991, Dr. Starzl (in collaboration with fellow APS member and Nobel laureate Rolf Zinkernagel) delineated the previously enigmatic mechanisms of organ engraftment and proposed radical modifications of immunosuppression strategy that facilitates these mechanisms. This work served to improve clinical outcomes as well as the overall understanding of the function of the immune system. In recognition of his groundbreaking work, he was awarded the Jonathan E. Rhoads Medal for Distinguished Service to Medicine in 2002 and the National Medal of Science, the nation's highest scientific honor, in 2004. He received many other honors and awards, including the 2012 Lasker Award and the Blumberg Award from the Hepatitis B Foundation (2014), as well as 24 honorary doctorates from around the world. He published almost 2,200 scientific articles and four books, including his memoir entitled The Puzzle People: Memoirs of a Transplant Surgeon. Thomas Starzl was elected to membership in the American Philosophical Society in 1999. In 2016 the Society presented him with the Benjamin Franklin Medal for Distinguished Achievement in Science. The citation read, "Tom Starzl has transformed human organ transplantation from science fiction to reliable treatment of fatal diseases, virtually changing medical practice. Fifty years ago when the world had only a handful of surviving kidney transplant recipients he showed that rejection was reversible, allowing consistent success. His introduction of new immunosuppressive agents helped him to accomplish the first liver and multivisceral transplants. His studies explain liver regeneration and determine that this organ controls lipid metabolism. His discovery of persistent donor cell chimerism in successful recipients points the way to allograft tolerance without chronic immunosuppression. In recognition of his profound contributions the American Philosophical Society salutes Thomas E. Starzl by awarding him its highest honor." | |
31 | Name: | Dr. Lewis Thomas | | Institution: | Sloan-Kettering; Cornell University Medical College | | Year Elected: | 1976 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1913 | | Death Date: | 12/3/93 | | | |
32 | Name: | Dr. James C. Thompson | | Institution: | University of Texas Medical Branch | | Year Elected: | 2000 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1928 | | Death Date: | May 9, 2008 | | | |
33 | Name: | Dr. Bert Vogelstein | | Institution: | Howard Hughes Medical Institute & Johns Hopkins Oncology Center | | Year Elected: | 1995 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Living
| | Birth Date: | 1949 | | | | | Bert Vogelstein stands out among the leading contemporary workers in the field of the molecular genetic basis of cancer, with his work in the area of colorectal cancer of particular note. He has effectively proven the multi-step process of carcinogenesis from benign adenoma to metastasizing cancer, and he identified mutations in the APC gene as an early and very frequent change in sporadic colon cancer as well as a constitutional change in persons with familial polyps of the colon. He was also responsible for defining a new type of cancer-producing gene mutation, mapping to chromosome 2, in familial colon cancer, and for identifying a specific oncogene in gliomas (brain tumors). Dr. Vogelstein's contributions are of the greatest importance for understanding the progression of malignancy, for early diagnosis of cancer, and for prevention of cancer.
Currently Clayton Professor of Oncology at the Johns Hopkins Oncology Center as well as an investigator at the Howard Hughes Medical Institute, he has been affiliated with Johns Hopkins University since receiving his Ph.D. from that institution in 1974. Dr. Vogelstein's many awards include the Alison Eberlein Award for Outstanding Contributions to Leukemia Research (1968), the Gairdner Foundation International Award in Science (1992), the American Cancer Society's Medal of Honor (1992), the Richard Lounsbery Award of the National Academy of Sciences, to whose membership he was elected in 1992, the Charles Rodophe Brupbacher Prize for Cancer Research (2012), the Breakthrough Prize in Life Sciences (2013), the Dr. Paul Janssen Award for Biomedical Research (2015),and the Gruber Genetics Prize (2019). He is also a member of the National Cancer Institute and the American Academy of Arts & Sciences. | |
34 | Name: | Dr. Jean D. Wilson | | Institution: | University of Texas Southwestern Medical Center | | Year Elected: | 2000 | | Class: | 2. Biological Sciences | | Subdivision: | 204. Medicine, Surgery, Pathology and Immunology | | Residency: | Resident | | Living? : |
Deceased
| | Birth Date: | 1932 | | Death Date: | June 13, 2021 | | | | | Jean Wilson received an M.D. at the University of Texas Southwestern Medical Center in 1955 and joined its faculty in 1960. He served as Chief of the Division of Endocrinology and Metabolism from 1988-95 and is currently Charles Cameron Sprague Distinguished Chair in Biomedical Science and Professor of Internal Medicine. He is also a Professorial Fellow in the Department of Zoology at the University of Melbourne, Australia. He is the recipient of the Ernst Oppenheimer Award and the Fred Conrad Koch Award of the Endocrine Society, the Amory Prize of the American Academy of Arts & Sciences, the Henry Dale Medal of the Society for Endocrinology and the Kober Medal of the Association of American Physicians. He is a member of the American Academy of Arts & Sciences and the National Academy of Sciences and has served as president of the Association of American Physicians, the American Society for Clinical Investigation and the Endocrine Society. He discovered a new hormone in 1967 when he and his colleagues showed that the male sex steroid testosterone can be converted to a closely related but more potent hormone dihydrotestosterone by 5a-reductase, an enzyme predominantly located in target tissues. Through experiments in a variety of species he established a bihormonal theory of male sexual differentiation, namely that testosterone controls the development of the internal urogenital tract and that dihydrotestosterone controls the prostate gland and external genitalia. This work has had important clinical ramifications in that it made possible the elucidation of the underlying mechanisms responsible for several syndromes of abnormal sexual development and understanding of the role of dihydrotestosterone in controlling the growth of the prostate gland in man and animals. A direct consequence of these fundamental studies was the development of drugs to inhibit the conversion of testosterone to dihydrotestosterone, an approach that has been applied to the treatment of benign prostatic hyperplasia and male pattern baldness. He was elected a member of the American Philosophical Society in 2000. He died on June 13, 2021. | |
| |